Curated Video
FDA Advisers Back Novavax Vaccine As New U.S. Option
They hope Novavax will appeal to those who don't want an mRNA vaccine because trials showed it had fewer side effects.
Bloomberg
FDA Will Move to Ban Flavored E-Cigarettes, According to Trump Official
Sep.11 -- President Donald Trump called vaping a “problem” and his health secretary said the government would force companies to remove flavored vaping products from the market after reports of hundreds of U.S. cases of a mysterious...
Curated Video
NYT: FDA Holding Off On Approving Plasma As Coronavirus Treatment
The FDA was set to emergency authorize the treatment, but top health officials said there isn't enough supporting data.
Curated Video
FDA Authorizes First Electronic Cigarette
The agency said the Vuse Solo by R.J. Reynolds Vapor Company was deemed safe and effective at reducing cigarette consumption among adults.
Bloomberg
What Emergency FDA Authorization Means for Covid-19 Vaccine
Nov.20 -- Johns Hopkins Bloomberg School of Public Health Professor and Virologist Andrew Pekosz offers insight into emergency authorization of a vaccine as Pfizer Inc. and BioNTech SE plan to file Friday for use of their coronavirus...
Curated Video
FDA Retracts Emergency Use Of Hydroxychloroquine For COVID-19 Tests
The FDA said in a statement Monday the hydroxychloroquine and chloroquine aren't likely to help treat coronavirus patients
The Recount
Pfizer Will Allow Developing Nations to Make Its COVID Pill
Pfizer will allow its COVID pill to be made and sold inexpensively in 95 poorer nations. This royalty-free licensing deal, in tandem with Merck's similar arrangement, could dramatically alter the course of the pandemic.
Curated Video
FDA Authorizes Pfizer And Moderna Booster Shots For All Adults
Scientists previously advised the FDA to reject the Biden administration's plan to start distributing booster shots, citing a lack of supporting data.
Curated Video
FDA Authorizes At-Home Nasal Swab For COVID-19
The Food and Drug Administration authorized the Everlywell COVID-19 Test Home Collection Kit on Saturday.
Curated Video
Johnson & Johnson Recalls Baby Powder After Asbestos Discovery
The company said it's voluntarily recalling one lot of its baby powder after the FDA found trace amounts of asbestos in a bottle purchased online.
Bloomberg
Novavax to File Vaccine in U.K. and U.S. in Q2, CEO Says
Mar.12 -- Novavax Inc. Chief Executive Officer Stan Erck says the company's Covid-19 vaccine has been effective against variants. He speaks with Bloomberg's Alix Steel on "Bloomberg Markets."
Curated Video
Pfizer Seeking FDA Approval For Vaccinating Children 12-15
Last week, Pfizer said late-stage clinical trials showed the vaccine was safe and 100% effective for children in that age bracket.
Bloomberg
J&J Pause Was Right Decision, FDA Advisory Panel Member Says
Apr.19 -- Dr. Ofer Levy, FDA advisory panel member and Boston Children's Hospital Precision Vaccines Program director, discusses the outlook for pediatric vaccination and says the Johnson & Johnson Covid-19 vaccine was the right decision...
Curated Video
FDA Approves Remdesivir To Treat Children With COVID-19
The FDA announced Monday that it approved use of the antiviral medication to treat patients as young as 28 days old.
Bloomberg
U.S. FDA to Authorize Covid Pills
New Covid treatments from Pfizer Inc. and Merck & Co. Inc. could be set for approval in the U.S. this week in what would be a significant development in the fight against the pandemic. Bloomberg's Michelle Cortez reports on "Bloomberg...
Bloomberg
Valeant Scores a Rare Win: Have They Turned a Corner?
July 20 -- Anthony Scilipoti, Veritas Investment Research president and chief executive officer, reacts to the decision by a panel of FDA experts who voted unanimously that Valeant's plaque psoriasis drug, brodalumab, deserved approval....
Bloomberg
Pitts: Carson Block's St. Jude Comments Are a Market Play
Peter Pitts, former FDA associate commissioner, reacts to Muddy Waters founder Carson Block's bet against the financial strength of St. Jude Medical. He speaks with Bloomberg's Scarlet Fu, Joe Weisenthal and Matt Miller on "What'd You...
Bloomberg
Bayer, Monsanto CEOs on Getting Deal Done
Sept. 14 -- Werner Baumann, chief executive officer at Bayer, and Hugh Grant, chairman and chief executive officer at Monsanto, discuss the $66 billion merger deal. They speak on "Bloomberg ‹GO›."
Bloomberg
Harvard's Jha Disappointed With Covid Plasma Announcement
Aug.24 -- Harvard Global Health Institute Director Dr. Ashish Jha says the U.S. Food and Drug Administration's confirmation that an Emergency Use Authorization was granted for the use of Covid-19 convalescent plasma for the treatment of...
Curated Video
FDA Authorizes At-Home Nasal Swab For COVID-19
The Food and Drug Administration authorized the Everlywell COVID-19 Test Home Collection Kit on Saturday.
Curated Video
Delta Variant Set To Become Dominant in U.S.
Former FDA commissioner Dr. Scott Gottlieb says the COVID-19 Delta variant will likely become the most dominant strain in the U.S.
Curated Video
What If Multiple COVID-19 Vaccines Are Approved?
AstraZeneca vaccine doesn't require super-cold storage temperatures, making it easier to get to poorer parts of the world.
Curated Video
Top U.S. Doctors Hope These Treatments Can Bridge The Gap To A Vaccine
At least eight COVID-19 vaccines are in clinical development. Medical officials are hoping treatments could buy us time until one is available.
Curated Video
Nearly Half Of U.S. Population Has Received 1 COVID Shot
The country reported fewer than 25,000 daily cases for the first time since June.